The Telegraph reported that an arthritis drug, Etanercept (Enbrel), could significantly improve the signs and symptoms of psoriasis in children.
The report is based on a double-blind randomised controlled trial published in New England Journal of Medicine, involving 211 children with psoriasis. The patients received weekly injections of etanercept or placebo for 12 weeks, followed by a 24-week period when all patients received etanercept and a 12-week period when patients were randomised to etanercept or placebo. The author concluded that Etanercept significantly reduced disease severity in children and adolescents with moderate to severe plaque psoriasis
Source: "Etanercept Treatment for Children and Adolescents with Plaque Psoriasis" NEJM 2008 358(3):241-251
No comments:
Post a Comment